PRL

PSP Research LLC Portfolio holdings

AUM $114M
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$114M
AUM Growth
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
85
New
Increased
Reduced
Closed

Top Buys

1 +$70.3M
2 +$584K
3 +$584K
4
TYRA icon
Tyra Biosciences
TYRA
+$575K
5
PHVS icon
Pharvaris
PHVS
+$569K

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 38.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STOK icon
51
Stoke Therapeutics
STOK
$1.74B
$528K 0.46%
+16,621
APGE icon
52
Apogee Therapeutics
APGE
$4.24B
$527K 0.46%
+6,984
CRNX icon
53
Crinetics Pharmaceuticals
CRNX
$4.59B
$527K 0.46%
+11,316
UTHR icon
54
United Therapeutics
UTHR
$20.6B
$526K 0.46%
+1,080
MAZE
55
Maze Therapeutics
MAZE
$2.11B
$525K 0.46%
+12,672
DNTH icon
56
Dianthus Therapeutics
DNTH
$2.01B
$524K 0.46%
+12,725
DNLI icon
57
Denali Therapeutics
DNLI
$3.13B
$524K 0.46%
+31,762
ALNY icon
58
Alnylam Pharmaceuticals
ALNY
$43.8B
$524K 0.46%
+1,318
EXEL icon
59
Exelixis
EXEL
$11.4B
$524K 0.46%
+11,948
XENE icon
60
Xenon Pharmaceuticals
XENE
$3.12B
$523K 0.46%
+11,678
NAMS icon
61
NewAmsterdam Pharma
NAMS
$3.64B
$523K 0.46%
+14,920
CELC icon
62
Celcuity
CELC
$4.83B
$523K 0.46%
+5,244
KNSA icon
63
Kiniksa Pharmaceuticals
KNSA
$3.23B
$522K 0.46%
+12,655
BMRN icon
64
BioMarin Pharmaceuticals
BMRN
$11B
$521K 0.46%
+8,772
OCUL icon
65
Ocular Therapeutix
OCUL
$1.94B
$520K 0.45%
+42,853
MDGL icon
66
Madrigal Pharmaceuticals
MDGL
$10.5B
$519K 0.45%
+892
SNDX icon
67
Syndax Pharmaceuticals
SNDX
$1.75B
$519K 0.45%
+24,716
SYRE icon
68
Spyre Therapeutics
SYRE
$2.56B
$519K 0.45%
+15,840
VKTX icon
69
Viking Therapeutics
VKTX
$2.97B
$518K 0.45%
+14,714
IMVT icon
70
Immunovant
IMVT
$4.85B
$516K 0.45%
+20,305
BEAM icon
71
Beam Therapeutics
BEAM
$2.51B
$508K 0.44%
+18,334
RYTM icon
72
Rhythm Pharmaceuticals
RYTM
$6.93B
$507K 0.44%
+4,738
VERA icon
73
Vera Therapeutics
VERA
$2.91B
$506K 0.44%
+9,996
INBX icon
74
Inhibrx
INBX
$1.19B
$505K 0.44%
+6,389
CRSP icon
75
CRISPR Therapeutics
CRSP
$4.37B
$502K 0.44%
+9,580